Michael Thomas Henderson, Director, on May 08, 2026, sold 80,000 shares in Spyre Therapeutics (SYRE) for $5,952,050. Following the Form 4 filing with the SEC, Henderson has control over a total of 88,606 common shares of the company, with 88,606 shares held directly.
SEC Filing:
Sachin Jain, Chief Operating Officer, on May 06, 2026, sold 7,335 shares in Coreweave (CRWV) for $961,839. Following the Form 4 filing with the SEC, Jain has control over a total of 104,068 Class A common shares of the company, with 104,068 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1769628/000176962826000225/xslF345X05/form4.xml
Brian M Venturo, Director, Chief Strategy Officer, on May 06, 2026, sold 76,924 shares in Coreweave (CRWV) for $10,515,594. Following the Form 4 filing with the SEC, Venturo has control over a total of 411,446 Class A common shares of the company, with 223,580 shares held directly and 187,866 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1769628/000176962826000226/xslF345X05/form4.xml
Dominic Bardos, Chief Financial Officer, on May 08, 2026, sold 54,449 shares in Shoals Technologies Group (SHLS) for $461,728. Following the Form 4 filing with the SEC, Bardos has control over a total of 394,979 Class A common shares of the company, with 394,979 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1831651/000183165126000085/xslF345X05/wk-form4_1778276020.xml